Loteprednol Etabonate: all 49 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant RejectionCompletedNCT05136443Phase 4Results postedHow we know
- Comparing Treatment of Dry Eye With Intracanalicular Dexamethasone, Restasis, and/or LotemaxCompletedNCT04555694Phase 4Results postedHow we know
- Safety and Efficacy of KPI-121 in Subjects With DEDCompletedNCT03616899Phase 3Results postedHow we know
- KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in ChildrenTerminatedNCT03596723Phase 3Results postedHow we know
- Loteprednol vs. Prednisolone and FluorometholoneCompletedNCT03123614Phase 4Results postedHow we know
- Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye DiseaseCompletedNCT02819284Phase 3Results postedHow we know
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseCompletedNCT02813265Phase 3Results postedHow we know
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation and PainCompletedNCT02793817Phase 3Results postedHow we know
- Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular EdemaCompletedNCT02245516Not applicableResults postedHow we know
- Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland DiseaseCompletedNCT02218489Phase 2Results postedHow we know
- Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryCompletedNCT02208297Phase 3Results postedHow we know
- Safety and Efficacy of KPI-121 in Subjects With Dry Eye DiseaseCompletedNCT02188160Phase 2Results postedHow we know
- Safety and Efficacy of KPI-121 in Subjects With Postsurgical InflammationCompletedNCT02163824Phase 3Results postedHow we know
- The Utility of IVCM to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With DEDCompletedNCT02120079Phase 4Results postedHow we know
- Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract SurgeryCompletedNCT01996839Phase 3Results postedHow we know
- Comparison of Corticosteroid Dosing Regimens After Endothelial KeratoplastyCompletedNCT01853696Phase 4Results postedHow we know
- Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)CompletedNCT01817582Phase 2Results postedHow we know
- Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single InstillationCompletedNCT01736527Phase 1Results postedHow we know
- Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%CompletedNCT01695668Not applicableResults postedHow we know
- Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children.CompletedNCT01475643Phase 3Results postedHow we know
- Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/BlepharitisCompletedNCT01456780Phase 4Results postedHow we know
- Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic ConjunctivitisCompletedNCT01443442Phase 4Results postedHow we know
- Alrex® Versus Patanol in the Treatment of Seasonal Allergic Conjunctivitis(SAC)CompletedNCT01435460Phase 3Results postedHow we know
- Loteprednol Ophthalmic Base Compared to Loteprednol Ophthalmic Suspension vs Placebo in an Allergen ChallengeCompletedNCT01107405Phase 2Results postedHow we know
- Evaluation of Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract SurgeryCompletedNCT01060072Phase 3Results postedHow we know
- Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of BlepharokeratoconjunctivitisCompletedNCT01028027Phase 3Results postedHow we know
- Loteprednol Etabonate Versus Vehicle for the Treatment of Inflammation and Pain Following Cataract SurgeryCompletedNCT01010633Phase 3Results postedHow we know
- Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric BlepharoconjunctivitisCompletedNCT00705159Phase 4Results postedHow we know
- Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract SurgeryCompletedNCT00699153Phase 3Results postedHow we know
- Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) ModelCompletedNCT00689078Phase 4Results postedHow we know
- Loteprednol Etabonate Versus Prednisolone Acetate for Anterior Chamber GranulomasCompletedNCT07496060Phase 4How we know
- Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour PeriodCompletedNCT07090044Phase 4How we know
- The Role of Loteprednol in Reducing Post-Intravitreal Injection Related PainCompletedNCT05542381Not applicableHow we know
- Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis TrialCompletedNCT05353101Phase 1How we know
- Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent PterygiumCompletedNCT04075227Phase 4How we know
- Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract SurgeryCompletedNCT03531697Phase 1How we know
- Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular InstallationsCompletedNCT03098953Phase 1How we know
- Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up StudyStatus unknownNCT02974387Phase 4How we know
- Topical Steroid Treatment For Dry EyeStatus unknownNCT02218827Not applicableHow we know
- A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®WithdrawnNCT02028312Phase 4How we know
- Comparison the Effects of Dexamethasone and Loteprednol on Epithelial HealingCompletedNCT01724892Phase 4How we know
- A Study to Evaluate the Safety and Efficacy of Lotemax Ophthalmic Suspension 0.5%CompletedNCT01437982Phase 4How we know
- Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following PhacoemulsificationStatus unknownNCT01193504Phase 4How we know
- Use of Loteprednol for Contact Lens Intolerance and DrynessStatus unknownNCT00817557Phase 4How we know
- Intraocular Pressure With Loteprednol and DexamethasoneCompletedNCT00781300Phase 4How we know
- Loteprednol Etabonate Opthalmic Suspension for the Treatment of Dry EyeCompletedNCT00560638Phase 2How we know
- Ocular Tolerance and Intraocular Pressure (IOP) Effects of Zylet Versus TobradexCompletedNCT00532961Phase 4How we know
- Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With RestasisCompletedNCT00407043Phase 4How we know
- Comparison of Acular LS With Lotemax to Prevent Inflammation After Cataract Surgery and Intraocular Lens ImplantationCompletedNCT00366691Phase 4How we know